0002033991--12-31 Q3 http://fasb.org/us-gaap/2025#RelatedPartyMember false 0002033991 us-gaap:MeasurementInputSharePriceMember 2025-09-30 0002033991 us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-09-30 0002033991 us-gaap:MeasurementInputOptionVolatilityMember 2025-09-30 0002033991 us-gaap:MeasurementInputExpectedTermMember 2025-09-30 0002033991 us-gaap:MeasurementInputExpectedDividendRateMember 2025-09-30 0002033991 us-gaap:MeasurementInputComparabilityAdjustmentMember 2025-09-30 0002033991 us-gaap:MeasurementInputSharePriceMember 2025-04-24 0002033991 us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-04-24 0002033991 us-gaap:MeasurementInputOptionVolatilityMember 2025-04-24 0002033991 us-gaap:MeasurementInputExpectedTermMember 2025-04-24 0002033991 us-gaap:MeasurementInputExpectedDividendRateMember 2025-04-24 0002033991 us-gaap:MeasurementInputComparabilityAdjustmentMember 2025-04-24 0002033991 us-gaap:FairValueInputsLevel3Member 2025-09-30 0002033991 tva:NMSIWarrantsMember 2025-04-24 0002033991 us-gaap:CommonClassAMember 2025-06-30 0002033991 us-gaap:AdditionalPaidInCapitalMember 2024-07-26 2024-09-30 0002033991 tva:FounderShares1Member us-gaap:OverAllotmentOptionMember 2025-04-24 2025-04-24 0002033991 us-gaap:OverAllotmentOptionMember 2025-01-01 2025-09-30 0002033991 us-gaap:OverAllotmentOptionMember 2024-01-01 2024-12-31 0002033991 tva:FounderShares1Member 2025-04-24 2025-04-24 0002033991 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-04-01 2025-06-30 0002033991 tva:FounderShares1Member tva:SponsorMember 2025-01-01 2025-09-30 0002033991 tva:FounderShares1Member 2024-08-01 2024-08-01 0002033991 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-07-26 2024-09-30 0002033991 us-gaap:RetainedEarningsMember 2025-09-30 0002033991 us-gaap:RetainedEarningsMember 2025-06-30 0002033991 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0002033991 2025-06-30 0002033991 us-gaap:RetainedEarningsMember 2025-03-31 0002033991 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0002033991 2025-03-31 0002033991 us-gaap:RetainedEarningsMember 2024-12-31 0002033991 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0002033991 us-gaap:RetainedEarningsMember 2024-09-30 0002033991 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0002033991 us-gaap:RetainedEarningsMember 2024-07-25 0002033991 us-gaap:AdditionalPaidInCapitalMember 2024-07-25 0002033991 2024-07-25 0002033991 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-06-30 0002033991 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-03-31 0002033991 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-09-30 0002033991 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-07-25 0002033991 2025-04-24 0002033991 us-gaap:WarrantMember us-gaap:CommonClassAMember 2025-09-30 0002033991 tva:PublicSharesMember 2025-09-30 0002033991 us-gaap:WarrantMember 2025-01-01 2025-09-30 0002033991 tva:PrivatePlacementWarrantsMember 2025-01-01 2025-09-30 0002033991 us-gaap:IPOMember 2025-04-24 2025-04-24 0002033991 us-gaap:CommonClassAMember 2025-01-01 2025-06-30 0002033991 tva:SingleReportableSegmentMember 2024-07-26 2024-09-30 0002033991 us-gaap:RelatedPartyMember 2025-09-30 0002033991 us-gaap:RelatedPartyMember 2024-12-31 0002033991 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0002033991 2025-01-01 2025-03-31 0002033991 us-gaap:RetainedEarningsMember 2024-07-26 2024-09-30 0002033991 tva:SingleReportableSegmentMember 2025-07-01 2025-09-30 0002033991 tva:SingleReportableSegmentMember 2025-01-01 2025-09-30 0002033991 2024-01-01 2024-12-31 0002033991 us-gaap:FairValueInputsLevel3Member 2025-01-01 2025-09-30 0002033991 us-gaap:CommonClassBMember 2025-07-01 2025-09-30 0002033991 us-gaap:CommonClassAMember 2025-07-01 2025-09-30 0002033991 tva:ClassBNonRedeemableOrdinarySharesMember 2025-07-01 2025-09-30 0002033991 tva:ClassAordinarySharesSubjectToPossibleRedemptionMember 2025-07-01 2025-09-30 0002033991 tva:ClassBNonRedeemableOrdinarySharesMember 2025-01-01 2025-09-30 0002033991 tva:ClassAordinarySharesSubjectToPossibleRedemptionMember 2025-01-01 2025-09-30 0002033991 us-gaap:CommonClassBMember 2024-07-26 2024-09-30 0002033991 tva:ClassBNonRedeemableOrdinarySharesMember 2024-07-26 2024-09-30 0002033991 tva:PromissoryNotesMember 2024-08-01 2024-08-01 0002033991 us-gaap:CommonClassBMember 2025-01-01 2025-09-30 0002033991 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-09-30 0002033991 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-12-31 0002033991 tva:FounderShares1Member tva:SponsorMember 2025-09-30 0002033991 us-gaap:CommonClassBMember 2025-09-30 0002033991 us-gaap:CommonClassBMember 2024-12-31 0002033991 us-gaap:CommonClassAMember 2024-12-31 0002033991 us-gaap:IPOMember 2025-09-30 0002033991 tva:NMSIPrivatePlacementWarrantsMember 2025-09-30 0002033991 tva:PublicWarrantsMember 2025-04-24 0002033991 tva:PrivatePlacementWarrantsMember 2025-04-24 0002033991 tva:NMSIPrivatePlacementWarrantsMember 2025-04-24 0002033991 tva:PrivatePlacementWarrantsMember tva:SponsorMember 2025-09-30 0002033991 tva:PrivatePlacementWarrantsMember tva:JVBFinancialGroupLLCAndClearStreetLLCMember 2025-09-30 0002033991 tva:PublicWarrantsMember us-gaap:CommonClassAMember 2025-09-30 0002033991 us-gaap:WarrantMember 2025-09-30 0002033991 us-gaap:CommonClassAMember 2025-09-30 0002033991 tva:PublicWarrantsMember 2025-09-30 0002033991 us-gaap:CommonClassAMember 2025-04-24 0002033991 2024-09-30 0002033991 srt:MinimumMember 2025-09-18 0002033991 tva:SingleReportableSegmentMember 2024-12-31 0002033991 us-gaap:FairValueInputsLevel1Member 2025-09-30 0002033991 tva:SingleReportableSegmentMember 2025-09-30 0002033991 us-gaap:OverAllotmentOptionMember 2025-09-30 0002033991 2025-05-01 2025-05-01 0002033991 us-gaap:IPOMember 2025-04-24 0002033991 us-gaap:OverAllotmentOptionMember 2025-04-24 0002033991 tva:PrivatePlacementWarrantsMember 2025-09-18 0002033991 tva:NMSIPrivatePlacementWarrantsMember 2025-09-18 0002033991 tva:FounderShares1Member us-gaap:CommonClassBMember 2025-09-18 0002033991 us-gaap:CommonClassBMember 2025-09-18 0002033991 us-gaap:PrivatePlacementMember 2025-09-30 0002033991 srt:MinimumMember 2025-01-01 2025-09-30 0002033991 srt:MaximumMember 2025-01-01 2025-09-30 0002033991 2025-09-18 2025-09-18 0002033991 tva:NMSIPrivatePlacementWarrantsMember 2025-01-01 2025-09-30 0002033991 us-gaap:CommonClassAMember 2025-04-24 2025-04-24 0002033991 tva:RedeemablePublicWarrantMember 2025-04-24 2025-04-24 0002033991 2025-04-24 2025-04-24 0002033991 tva:NonManagingSponsorInvestorsMember 2025-01-01 2025-09-30 0002033991 us-gaap:PrivatePlacementMember 2025-01-01 2025-09-30 0002033991 2025-09-30 0002033991 2024-07-26 2024-09-30 0002033991 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0002033991 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0002033991 tva:PrivatePlacementWarrantsMember 2025-09-30 0002033991 tva:NonManagingSponsorInvestorsMember 2025-09-30 0002033991 us-gaap:CommonClassAMember 2025-01-01 2025-09-30 0002033991 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0002033991 2025-04-01 2025-06-30 0002033991 2024-12-31 0002033991 2025-07-01 2025-09-30 0002033991 tva:UnitsEachConsistingOfOneClassAOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember 2025-01-01 2025-09-30 0002033991 tva:RedeemableWarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150PerShareMember 2025-01-01 2025-09-30 0002033991 tva:ClassAOrdinarySharesParValue00001ParValueMember 2025-01-01 2025-09-30 0002033991 us-gaap:CommonClassBMember 2025-11-19 0002033991 us-gaap:CommonClassAMember 2025-11-19 0002033991 dei:FormerAddressMember 2025-01-01 2025-09-30 0002033991 2025-01-01 2025-09-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares tva:item xbrli:pure tva:segment tva:Y

Table of Contents

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(MARK ONE)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2025

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-42609

Texas Ventures Acquisition III Corp

(Exact Name of Registrant as Specified in Its Charter)

​

Cayman Islands |  | 98-1802457
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)
1012 Springfield Avenue Mountainside, New Jersey |  | 07092
(Address of principal executive offices) |  | (Zip Code)

​

(201) 985-8300

(Registrant’s telephone number, including area code)

5090 Richmond Ave, Suite 319

Houston, Texas 77056

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

​

Title of each class |  | Trading Symbol(s) |  | Name of each exchange on which registered
Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant |  | TVACU |  | The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 par value |  | TVA |  | The Nasdaq Stock Market LLC
Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share |  | TVACW |  | The Nasdaq Stock Market LLC

​

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

​

|  | ​ |  |
Large accelerated filer | ☐ |  | Accelerated filer | ☐
Non-accelerated filer | ☒ | ​ | Smaller reporting company | ☒
| ​ | Emerging growth company | ☒

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

As of November 19, 2025, there were 22,500,000 Class A ordinary shares, par value $0.0001 per share, and 7,500,000 Class B ordinary shares, par value $0.0001 per share, issued and outstanding.

​

​

​

Table of Contents

TEXAS VENTURES ACQUISITION III CORP

FORM 10-Q FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2025

TABLE OF CONTENTS

| Page
PART I - FINANCIAL INFORMATION | 1
Item 1. | Unaudited Condensed Financial Statements | 1
| Condensed Balance Sheets as of September 30, 2025 (unaudited) and December 31, 2024 | 1
​ | Condensed Unaudited Statements of Operations for the three and nine months ended September 30, 2025 and for the period from July 26, 2024 (inception) through September 30, 2024 | 2
​ | Condensed Unaudited Statements of Changes in Shareholders’ Deficit for the three and nine months ended September 30, 2025 and for the period from July 26, 2024 (inception) through September 30, 2024 | 3
​ | Condensed Unaudited Statements of Cash Flows for the nine months ended September 30, 2025 and for the period from July 26, 2024 (inception) through September 30, 2024 | 4
​ | Notes to Unaudited Condensed Financial Statements | 5
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 21
Item 3. | Quantitative and Qualitative Disclosures about Market Risk | 24
Item 4. | Controls and Procedures | 25
PART II - OTHER INFORMATION | 26
Item 1. | Legal Proceedings | 26
Item 1A. | Risk Factors | 26
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 26
Item 3. | Defaults upon Senior Securities | 26
Item 4. | Mine Safety Disclosures | 26
Item 5. | Other Information | 26
Item 6. | Exhibits | 27
SIGNATURES | 28

​

​

i

Table of Contents

Unless otherwise stated in this Report (as defined below), or the context otherwise requires, references to:

| ● | “Administrative Services Agreement” are to the Administrative Services Agreement, dated April 22, 2025, which we entered into with our Prior Sponsor (as defined below), and which was terminated effective September 18, 2025 as of the closing of the transactions provided for by the Purchase Agreement;

| ● | “Amended and Restated Articles” are to our Amended and Restated Memorandum and Articles of Association, as currently in effect;

| ● | “ASC” are to the FASB (as defined below) Accounting Standards Codification;

| ● | “ASU” are to the FASB Accounting Standards Update;

| ● | “Board of Directors” or “Board” are to our board of directors;

| ● | “Business Combination” are to a merger, capital share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses;

| ● | “Class A Ordinary Shares” are to our Class A ordinary shares, par value $0.0001 per share;

| ● | “Class B Ordinary Shares” are to our Class B ordinary shares, par value $0.0001 per share;

| ● | “Clear Street” means Clear Street LLC;

| ● | “Cohen & Company” means Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC;

| ● | “Combination Period” are to the eighteen-month period, from the closing of the Initial Public Offering (as defined below) to October 24, 2026 (or such earlier date as determined by the Board) that we have to consummate an initial Business Combination; provided that the Combination Period may be extended pursuant to an amendment to the Amended and Restated Articles and consistent with applicable laws, regulations and stock exchange rules;

| ● | “Companies Act” are to the Companies Act (As Revised) of the Cayman Islands, as may be amended from time to time;

| ● | “Company,” “our,” “we” or “us” are to Texas Ventures Acquisition III Corp, a Cayman Islands exempted company;

| ● | “Continental” are to Continental Stock Transfer & Trust Company, trustee of our Trust Account (as defined below) and warrant agent of our Public Warrants (as defined below);

| ● | “Deferred Fee” are to the additional fee of up to 4% of the gross proceeds of the Initial Public Offering to which the underwriters to the Initial Public Offering are entitled that is payable only upon our completion of the initial Business Combination and based on the percentage of funds remaining in the Trust Account (as defined below) after redemptions of public shares;

| ● | “Exchange Act” are to the Securities Exchange Act of 1934, as amended;

| ● | “FASB” are to the Financial Accounting Standards Board;

| ● | “Founder Shares” are to the Class B Ordinary Shares initially purchased by our Prior Sponsor prior to the Initial Public Offering and the Class A Ordinary Shares that will be issued upon the automatic conversion of the Class B Ordinary Shares at the time of our Business Combination as described herein (for the avoidance of doubt, such Class A Ordinary Shares will not be “Public Shares” (as defined below)). Following closing of the transactions provided for by the Purchase Agreement (as defined below), the Founder Shares are held by the New Sponsor (as defined below);

| ● | “GAAP” are to the accounting principles generally accepted in the United States of America;

ii

Table of Contents

| ● | “Initial Public Offering” or “IPO” are to the initial public offering that we consummated on April 24, 2025;

| ● | “Insider Letter” are to the letter agreement, dated September 18, 2025, by and among the Company, the New Sponsor and the individuals designated to become officers and directors upon the closing of the transactions provided for by the Purchase Agreement, addressing, among other things, voting obligations and certain transfer restrictions applicable to the New Sponsor and such individuals;

| ● | “Investment Company Act” are to the Investment Company Act of 1940, as amended;

| ● | “IPO Promissory Note” are to that certain unsecured promissory note in the principal amount of up to $300,000 issued to our Prior Sponsor on August 1, 2024 and as amended and restated on March 14, 2025;

| ● | “IPO Registration Statement” are to the Registration Statement on Form S-1 initially filed with the SEC on February 10, 2025, as amended, and declared effective on April 22, 2025 (File No. 333-284793);

| ● | “JOBS Act” are to the Jumpstart Our Business Startups Act of 2012;

| ● | “Letter Agreement” are to the Letter Agreement, dated April 22, 2025, which we entered into with our Prior Sponsor and the individuals then serving as our directors and officers, which, pursuant to the Waiver of Joinder Requirement under Insider Letter and the Purchase Agreement, dated September 18, 2025, did not require the New Sponsor to execute a joinder and was terminated effective as of the closing of the transactions provided for by the Purchase Agreement;

| ● | “Management” or our “Management Team” are to our executive officers and directors;

| ● | “non-managing sponsor investors” means seven institutional investors (none of which are affiliated with any member of Management, other members of our Prior Sponsor or any other investor) that prior to September 18, 2025, purchased, indirectly, through the purchase of non-managing sponsor membership interests in the Prior Sponsor, an aggregate of 4,100,000 Private Placement Warrants (defined below) at a price of $1.00 per warrant ($4,100,000 in the aggregate); in connection with the non-managing sponsor investor indirectly purchasing, through the Prior Sponsor, the NMSI Private Placement Warrants (defined below) allocated to it in connection with the closing of this offering, the Sponsor issued membership interests at a nominal purchase price to the non-managing sponsor investors at the closing of the IPO reflecting interests in an aggregate of 3,280,000 Founder Shares then held by the Prior Sponsor. Pursuant to the Purchase Agreement, the non‑managing sponsor investors have no further rights, claims or interests in or to any securities of the Company (other than any Public Units, Public Shares or Public Warrants they may hold), and all such Private Placement Warrants are held by the New Sponsor following the closing of the transactions provided for by the Purchase Agreement;

| ● | “NMSI Private Placement Warrants” means the subset of Private Placement Warrants that, prior to September 18, 2025, were designated to be distributed to non-managing sponsor investors by the Prior Sponsor upon closing of our initial Business Combination. Following the closing of the transactions provided for by the Purchase Agreement on September 18, 2025, no such Private Placement Warrants are held by, or are distributable to, any non‑managing sponsor investor, and no consent, exchange or other special rights applicable solely to the NMSI Private Placement Warrants are in effect, and all such Private Placement Warrants are held by the New Sponsor following the closing of the transactions provided for by the Purchase Agreement;

| ● | “Nasdaq” are to the Nasdaq Stock Market LLC;

| ● | “Nasdaq 36-Month Requirement” are to the requirement pursuant to the Nasdaq Rules (as defined below) that a SPAC (as defined below) must complete one or more Business Combinations within 36 months following the effectiveness of its Initial Public Offering registration statement;

| ● | “Nasdaq Rules” are to the continued listing rules of Nasdaq, as they exist as of the date of this Report;

| ● | “New Sponsor” are to Yorkville Acquisition Sponsor II, LLC, a Florida limited liability company;

iii

Table of Contents

| ● | “Ordinary Shares” are to the Class A Ordinary Shares and the Class B Ordinary Shares, together;

| ● | “Over-Allotment Option” are to the 45-day option that the underwriters of the Initial Public Offering had to purchase up to an additional 3,000,000 Units to cover over-allotments, if any, pursuant to the Underwriting Agreement (as defined below), which was partially exercised;

| ● | “Prior Sponsor” are to TV Partners III, LLC, a Delaware Limited Liability Company;

| ● | “Private Placement” are to the private placement of Private Placement Warrants (as defined below) that occurred simultaneously with the closing of our Initial Public Offering;

| ● | “Private Placement Warrants” are to the warrants initially issued to our Prior Sponsor and the underwriters of the Initial Public Offering in the Private Placement, with each Private Placement Warrant entitling the holder to purchase one Class A Ordinary Share. Following the closing of the transactions provided for by the Purchase Agreement, the 4,700,000 Private Placement Warrants originally issued to the Prior Sponsor have been sold by the Prior Sponsor to, and are held by, the New Sponsor (subject to permitted transfers), and the remaining Private Placement Warrants are held by the underwriters (or their permitted transferees). For the avoidance of doubt, there no longer are any Private Placement Warrants issued indirectly to the non‑managing sponsor investors;

| ● | “Private Placement Warrants Purchase Agreements” are to the Private Placement Warrants Purchase Agreement, dated April 22, 2025, by and between us and the Prior Sponsor, and the Private Placement Warrants Purchase Agreement, dated April 22, 2025, by and among us, Cohen & Company and Clear Street (in each case as amended, restated, supplemented or otherwise modified from time to time);

| ● | “Public Shares” are to the Class A Ordinary Shares sold as part of the Public Units (as defined below) in our Initial Public Offering (whether they were purchased in our Initial Public Offering or thereafter in the open market);

| ● | “Public Shareholders” are to the holders of our Public Shares, including our initial shareholders, Management and any non-managing sponsor investors to the extent our initial shareholders, members of Management, and/or any non-managing sponsor investors purchase public shares, provided that the each initial shareholder’s, member of Management, and any non-managing sponsor investors’ status as a “Public Shareholder” will only exist with respect to such Public Share;

| ● | “Public Units” are to the units sold in our Initial Public Offering, which consist of one Public Share and one-half of one Public Warrant;

| ● | “Public Warrants” are to the redeemable warrants sold as part of the Public Units in our Initial Public Offering (whether they were subscribed for in our Initial Public Offering or purchased in the open market), with each Public Warrant entitling the holder to purchase one Class A Ordinary Share;

| ● | “Purchase Agreement” means that certain Purchase Agreement, dated September 18, 2025, by and among the Company, our Prior Sponsor, and our New Sponsor, as it may be amended, restated, supplemented or otherwise modified from time to time;

| ● | “Registration Rights Agreement” are to the Registration Rights Agreement, dated April 22, 2025, by and among the Company, the Prior Sponsor, Cohen & Company, Clear Street, and certain security holders party thereto, as joined and amended by the Joinder to and Amendment of the Registration Rights Agreement, dated September 18, 2025, by the New Sponsor (acknowledged and accepted by the Company and the Prior Sponsor), and as further amended, restated, supplemented or otherwise modified from time to time;

| ● | “Report” are to this Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025;

| ● | “Sarbanes-Oxley Act” are to the Sarbanes-Oxley Act of 2002;

| ● | “SEC” are to the U.S. Securities and Exchange Commission;

iv

Table of Contents

| ● | “Securities Act” are to the Securities Act of 1933, as amended;

| ● | “SPAC” are to a special purpose acquisition company;

| ● | “Sponsor” are to the Prior Sponsor prior to the closing of the Purchase and the New Sponsor post the closing of the Purchase;

| ● | “Trust Account” are to the U.S.-based trust account in which an amount of $226,125,000 from the net proceeds of the sale of the Public Units in the Initial Public Offering and the Private Placement Warrants in the Private Placement was placed following the closing of the Initial Public Offering;

| ● | “Trust Agreement” are to the Investment Management Trust Agreement, dated April 22, 2025, which we entered into with Continental, as trustee of the Trust Account;

| ● | “Units” are to the units sold in our Initial Public Offering, which consist of one Public Share and one-half of one Public Warrant;

| ● | “Warrants” are to the Private Placement Warrants and the Public Warrants, together;

| ● | “Withum” are to WithumSmith+Brown, PC, our independent registered public accounting firm; and

| ● | “Working Capital Loans” are to funds that, in order to provide working capital or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of our directors and officers may, but are not obligated to, loan us.

​

​

v

Table of Contents

PART I – FINANCIAL INFORMATION

Item 1. Unaudited Condensed Financial Statements

TEXAS VENTURES ACQUISITION III CORP

CONDENSED BALANCE SHEETS

​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | September 30, |  | December 31,
​ |  | 2025 |  | 2024
​ |  | (Unaudited) | ​ | ​
ASSETS |  | ​ |  |  | ​ |
Current Assets: |  | ​ |  |  | ​ |
Cash | ​ | $ | 876,477 | ​ | $ | 2,232
Prepaid expenses | ​ |  | 127,548 | ​ |  | 4,566
Total Current Assets | ​ |  | 1,004,025 | ​ |  | 6,798
​ | ​ | ​ | ​ | ​ | ​ | ​
Prepaid expenses, non-current | ​ |  | 58,333 | ​ |  | —
Investments held in Trust Account | ​ |  | 230,239,464 | ​ |  | —
Deferred offering costs | ​ |  | — | ​ |  | 248,425
Total Assets | ​ | $ | 231,301,822 | ​ | $ | 255,223
​ | ​ | ​ | ​ | ​ | ​ | ​
LIABILITIES AND SHAREHOLDERS’ DEFICIT | ​ |  | ​ | ​ |  |
Current Liabilities: | ​ |  | ​ | ​ |  |
Accrued expenses | ​ | $ | 19,912 | ​ | $ | —
Accrued offering costs | ​ |  | — | ​ |  | 122,760
Promissory note – related party | ​ |  | — | ​ |  | 152,200
Total Current Liabilities | ​ |  | 19,912 | ​ |  | 274,960
​ | ​ | ​ | ​ | ​ | ​ | ​
Warrant liability | ​ |  | 6,133,664 | ​ |  | —
Deferred underwriting commissions | ​ |  | 9,000,000 | ​ |  | —
Total Liabilities | ​ |  | 15,153,576 | ​ |  | 274,960
​ | ​ | ​ | ​ | ​ | ​ | ​
Commitments and contingencies (Note 6) | ​ |  | ​ | ​ |  |
Class A ordinary shares subject to possible redemption; 22,500,000 and 0 shares (at redemption value of $10.23 and $0) at September 30, 2025 and December 31, 2024, respectively | ​ |  | 230,239,464 | ​ |  | —
Shareholders’ Deficit: | ​ |  | ​ | ​ |  |
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding at September 30, 2025 and December 31, 2024 | ​ |  | — | ​ |  | —
Class A ordinary shares, $0.0001 par value, 500,000,000 shares authorized, none issued or outstanding at September 30, 2025 and December 31, 2024 | ​ |  | — | ​ |  | —
Class B ordinary shares, $0.0001 par value, 50,000,000 shares authorized, 7,500,000 and 7,666,667 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | ​ |  | 750 | ​ |  | 767
Additional paid-in capital | ​ |  | — | ​ |  | 24,233
Accumulated deficit | ​ |  | (14,091,968) | ​ |  | (44,737)
Total Shareholders’ Deficit | ​ |  | (14,091,218) | ​ |  | (19,737)
Total Liabilities and Shareholders’ Deficit | ​ | $ | 231,301,822 | ​ | $ | 255,223

​

See accompanying notes to the condensed financial statements.

​

1

Table of Contents

TEXAS VENTURES ACQUISITION III CORP

CONDENSED STATEMENTS OF OPERATIONS

(unaudited)

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | For the
​ | ​ | For the | ​ | For the | ​ | Period from July 26,
​ | ​ | Three Months Ended | ​ | Nine Months Ended | ​ | (inception) through
​ |  | September 30, | ​ | September 30, |  | September 30,
​ |  | 2025 |  | 2025 |  | 2024
EXPENSES |  | ​ |  | ​ | ​ |  |  | ​ |
General and administrative expenses | ​ | $ | 151,150 | ​ | $ | 427,662 |  | $ | 26,450
TOTAL EXPENSES | ​ | $ | 151,150 | ​ | $ | 427,662 |  | $ | 26,450
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
OTHER INCOME (LOSS) | ​ |  |  | ​ | ​ |  |  | ​ |
Interest income earned on investments held in Trust Account | ​ |  | 2,380,552 | ​ | ​ | 4,114,464 |  | ​ | —
Interest income earned on cash held in operating account | ​ |  | 10,674 | ​ | ​ | 17,143 |  | ​ | —
Forgiveness of debt | ​ | ​ | 28,614 | ​ | ​ | 28,614 | ​ | ​ | —
Change in the fair value of warrant liability | ​ |  | (3,469,346) | ​ | ​ | (2,033,664) |  | ​ | —
TOTAL OTHER INCOME (LOSS), NET | ​ |  | (1,049,506) | ​ | ​ | 2,126,557 |  | ​ | —
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net income (loss) | ​ | $ | (1,200,656) | ​ | $ | 1,698,895 | ​ | $ | (26,450)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Basic weighted average shares outstanding, Class A ordinary shares subject to possible redemption | ​ |  | 20,000,000 | ​ |  | 11,648,352 | ​ |  | —
Basic net income (loss) per share, Class A ordinary shares subject to possible redemption | ​ | $ | (0.04) | ​ | $ | 0.09 | ​ | $ | —
Diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption | ​ | ​ | 20,000,000 | ​ | ​ | 11,648,352 | ​ | ​ | ​
Diluted net income (loss) per share, Class A ordinary shares subject to possible redemption | ​ | $ | (0.04) | ​ | $ | 0.09 | ​ | $ | ​
Basic weighted average shares outstanding, Class B non-redeemable ordinary shares | ​ |  | 7,500,000 | ​ |  | 7,152,015 | ​ |  | 6,666,667
Basic net income (loss) per share, Class B non-redeemable ordinary shares | ​ | $ | (0.04) | ​ | $ | 0.09 | ​ | $ | (0.00)
Diluted weighted average shares outstanding, Class B non-redeemable ordinary shares | ​ |  | 7,500,000 | ​ |  | 7,222,222 | ​ |  | 6,666,667
Diluted net income (loss) per share, Class B non-redeemable ordinary shares | ​ | $ | (0.04) | ​ | $ | 0.09 | ​ | $ | (0.00)

​

See accompanying notes to the condensed financial statements.

​

2

Table of Contents

TEXAS VENTURES ACQUISITION III CORP

CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025 AND FOR THE PERIOD FROM JULY 26, 2024 (INCEPTION) THROUGH SEPTEMBER 30, 2024

(UNAUDITED)

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Class B | ​ | Additional | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Ordinary Shares |  | Paid-In | ​ | Accumulated |  | Shareholders’
​ |  | Shares |  | Amount |  | Capital |  | Deficit |  | Deficit
Balance, January 1, 2025 |  | 7,666,667 | ​ | $ | 767 | ​ | $ | 24,233 | ​ | $ | (44,737) | ​ | $ | (19,737)
Net loss |  | — | ​ |  | — | ​ |  | — | ​ |  | (39,596) | ​ |  | (39,596)
Balance, March 31, 2025 |  | 7,666,667 | ​ | $ | 767 | ​ | $ | 24,233 | ​ | $ | (84,333) | ​ | $ | (59,333)
Forfeiture of Class B ordinary shares |  | (166,667) | ​ |  | (17) | ​ |  | 17 | ​ |  | — | ​ |  | —
Sale of Private Placement Warrants |  | — | ​ |  | — | ​ |  | 3,468,500 | ​ |  | — | ​ |  | 3,468,500
Fair value of public warrants at issuance |  | — | ​ |  | — | ​ |  | 3,037,500 | ​ |  | — | ​ |  | 3,037,500
Accretion for Class A Ordinary Shares to redemption amount |  | — | ​ |  | — | ​ |  | (6,333,417) | ​ |  | (13,365,574) | ​ |  | (19,698,991)
Allocated value of transaction costs to Class A Ordinary Shares |  | — | ​ |  | — | ​ |  | (196,833) | ​ |  | — | ​ |  | (196,833)
Net income |  | — | ​ |  | — | ​ |  | — | ​ |  | 2,939,147 | ​ |  | 2,939,147
Balance, June 30, 2025 |  | 7,500,000 | ​ | $ | 750 | ​ | $ | — | ​ | $ | (10,510,760) | ​ | $ | (10,510,010)
Remeasurement of ordinary shares to redemption value |  | — | ​ |  | — | ​ |  | — | ​ |  | (2,380,552) | ​ |  | (2,380,552)
Net loss | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (1,200,656) | ​ | ​ | (1,200,656)
Balance, September 30, 2025 |  | 7,500,000 | ​ | $ | 750 | ​ | $ | — | ​ | $ | (14,091,968) | ​ | $ | (14,091,218)

​

​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Class B | ​ | Additional | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Ordinary Shares | ​ | Paid-In | ​ | Accumulated | ​ | Shareholders’
​ |  | Shares |  | Amount | ​ | Capital | ​ | Deficit | ​ | Deficit
Balance, July 26, 2024 |  | — |  | $ | — |  | $ | — |  | $ | — |  | $ | —
Issuance of Class B ordinary shares to Sponsor |  | 7,666,667 |  | ​ | 767 | ​ |  | 24,233 | ​ |  | — | ​ |  | 25,000
Net loss |  | — |  | ​ | — | ​ |  | — | ​ |  | (26,450) | ​ |  | (26,450)
Balance, September 30, 2024 |  | 7,666,667 |  | $ | 767 | ​ | $ | 24,233 | ​ | $ | (26,450) | ​ | $ | (1,450)

​

See accompanying notes to the condensed financial statements.

​

3

Table of Contents

TEXAS VENTURES ACQUISITION III CORP

CONDENSED STATEMENTS OF CASH FLOWS

(unaudited)

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | For the Period
​ |  | For the | ​ | from July 26, 2024
​ | ​ | Nine Months Ended | ​ | (inception) through
​ |  | September 30, | ​ | September 30,
​ |  | 2025 | ​ | 2024
Cash Flows from Operating Activities: |  | ​ |  | ​ | ​ |
Net income (loss) | ​ | $ | 1,698,895 | ​ | $ | (26,450)
Adjustments to reconcile net income (loss) to net cash used in operating activities: | ​ |  | ​ | ​ |  | ​
Interest earned on investments held in Trust Account | ​ |  | (4,114,464) | ​ |  | —
Change in the fair value of warrant liability | ​ |  | 2,033,664 | ​ |  | —
Changes in operating assets and liabilities: | ​ |  | ​ | ​ |  | ​
Prepaid expenses | ​ |  | (181,315) | ​ |  | (5,200)
Deferred offering costs | ​ |  | 248,425 | ​ |  | (43,780)
Accrued expenses | ​ |  | 19,912 | ​ |  | —
Accrued offering costs | ​ | ​ | (122,760) | ​ | ​ | —
Due to related party | ​ |  | — | ​ |  | 750
Net Cash used in Operating Activities | ​ |  | (417,643) | ​ |  | (74,680)
​ | ​ | ​ | ​ | ​ | ​ | ​
Cash Flows from Investing Activities: | ​ |  |  | ​ |  |
Cash deposited into Trust Account | ​ |  | (226,125,000) | ​ |  | —
Net Cash used in Investing Activities | ​ |  | (226,125,000) | ​ |  | —
​ | ​ | ​ | ​ | ​ | ​ | ​
Cash Flows from Financing Activities: | ​ |  |  | ​ |  |
Proceeds from the sale of Units | ​ |  | 226,125,000 | ​ |  | —
Proceeds from promissory note – related party | ​ |  | 397,800 | ​ |  | 55,000
Payment of promissory note – related party | ​ |  | (550,000) | ​ |  | —
Proceeds from sale of private placement warrants | ​ |  | 6,968,750 | ​ |  | —
Proceeds from issuance of Class B ordinary shares | ​ | ​ | — | ​ | ​ | 25,000
Payment of underwriting fee | ​ |  | (4,500,000) | ​ |  | —
Payment of offering costs | ​ |  | (1,024,662) | ​ |  | —
Net Cash Provided by Financing Activities | ​ |  | 227,416,888 | ​ |  | 80,000
Net change in cash | ​ |  | 874,245 | ​ |  | 5,320
Cash at beginning of period | ​ |  | 2,232 | ​ |  | —
Cash at end of period | ​ | $ | 876,477 | ​ | $ | 5,320
​ | ​ | ​ | ​ | ​ | ​ | ​
Supplemental disclosure of non-cash financing activities: | ​ |  |  | ​ |  |
Deferred underwriters’ discount payable | ​ | $ | 9,000,000 | ​ | $ | —
Deferred offering costs included in accrued offering costs | ​ | $ | — | ​ | $ | 8,288

​

See accompanying notes to the condensed financial statements.

​

4

Table of Contents

TEXAS VENTURES ACQUISITION III CORP

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2025 (UNAUDITED)

NOTE 1 — DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN

Texas Ventures Acquisition III Corp (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on July 26, 2024. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).

The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company, and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

On April 24, 2025, the Company consummated its Initial Public Offering (“Initial Public Offering” or “IPO”) of 22,500,000 units (the “Public Units” and, with respect to the Class A ordinary shares and public warrants included in the Public Units, the “Public Shares”, and “Public Warrants”, respectively), including 2,500,000 Units issued pursuant to the partial exercise of the underwriters’ over-allotment option. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $225,000,000. Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share.

Simultaneously with the closing of the IPO, the Company completed the private sale of 7,568,750 warrants (the “Private Placement Warrants”) to the Prior Sponsor, Cohen & Company and Clear Street at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $7,568,750. The Private Placement Warrants are identical to the Warrants sold in the Initial Public Offering, except as otherwise noted in Note 8.

On September 18, 2025, the Company, the Prior Sponsor and the New Sponsor entered into the Purchase Agreement. Pursuant to the Purchase Agreement, the New Sponsor (i) purchased from the Prior Sponsor (a) 7,500,000 shares of Class B Ordinary Shares and (b) 4,700,000 Private Placement Warrants, for an aggregate purchase price of $7,400,000 and (ii) upon closing, became the sponsor of the Company (together, the “Purchase”).

As conditions to the closing of the Purchase, all of the then-existing members of the Board of Directors (the “Prior Board”) and then-existing officers of the Company resigned, and the New Sponsor designated a new board of directors and new management team, which were appointed immediately prior to the closing of the Purchase. The New Sponsor also agreed, among other things, to (i) execute a joinder agreement (the “Joinder”) to become a party to the Registration Rights Agreement, and (ii) enter into the Insider Letter with the Company,” providing for, among other things, voting obligations and certain transfer restrictions. The Prior Sponsor and the Company, among other things, agreed to cause all parties to the Letter Agreement to, execute a waiver to certain requirements of the Letter Agreement such that the New Sponsor need not execute a joinder or become a party to the Letter Agreement.

In addition to the foregoing, the closing of the Purchase was conditional on, among other things, (i) the termination of all Company related party contracts and certain commercial arrangements, (ii) the payment of all outstanding invoices of the Company by the closing, (iii) the Company holding at least $875,000 in cash or cash equivalents, exclusive of the trust account, after payment of all outstanding liabilities, and (iv) the Company’s continued listing on the Nasdaq through the closing. Although the Purchase Agreement included as a condition to closing the execution of a written waiver by the Underwriters of the Company’s Initial Public Offering, reducing their rights to receive the deferred underwriting fee contemplated by the Underwriting Agreement, to a new agreed amount, this condition was not satisfied at closing of the Purchase. The New Sponsor consummated the Purchase notwithstanding the failure of this condition to be satisfied. The other conditions to the closing of the Purchase were satisfied.

Upon the closing of the Purchase, the New Sponsor became the sponsor of the Company, the new directors and officers designated by the New Sponsor assumed their positions, and, in accordance with the terms of the Joinder to become a party to the Registration Rights Agreement, the New Sponsor became a party to the Registration Rights Agreement.

Seven institutional investors (“non-managing sponsor investors”) previously purchased, indirectly, through the purchase of non-managing sponsor membership interests, an aggregate of 4,100,000 Private Placement Warrants at a price of $1.00 per warrant

5

Table of Contents

($4,100,000 in the aggregate). In connection with the such indirect purchase through the Prior Sponsor, the Prior Sponsor issued membership interests at a nominal purchase price to the non-managing sponsor investors reflecting interests in an aggregate of 3,280,000 Founder Shares then held by the Prior Sponsor. Historically, the NMSI Private Placement Warrants were held by the Prior Sponsor and designated to be transferred to the non-managing sponsor investors only upon the consummation of an initial Business Combination. Following the closing of the transactions provided for by the Purchase Agreement on September 18, 2025, the non-managing sponsor investors have no further rights, claims or interests in or to any Sponsor‑held securities (including any NMSI Private Placement Warrants or NMSI Shares), and there are no NMSI‑specific consent, exchange or other special rights in effect.

Transaction costs for the Initial Public Offering amounted to $14,006,902, consisting of $4,500,000 of cash underwriting fees, $9,000,000 of deferred underwriting fees, and $506,902 of other offering costs.

On April 24, 2025, the underwriters partially exercised the over-allotment option of 2,500,000 Units and informed the Company that they would not further exercise the option for the remaining 500,000 Units. As a result, the Prior Sponsor forfeited an aggregate 166,667 Founder Shares of the Company, par value $0.0001 per share. Such forfeited shares were cancelled by the Company upon consummation of the Initial Public Offering.

Upon the closing of the Initial Public Offering and the Private Placement, $226,125,000 ($10.05 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described in the IPO Registration Statement. The proceeds deposited in the Trust Account could become subject to the claims of creditors, if any, which could have priority over the claims of public shareholders.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The stock exchange listing rules require that the Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the amount of deferred underwriting commissions and taxes payable on the income earned on the Trust Account). The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination.

The Company will provide the holders of the outstanding Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer in connection with the Business Combination. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.05 per Public Share, plus any pro rata interest then in the Trust Account). There will be no redemption rights upon the completion of a Business Combination with respect to the Private Placement Warrants. The Public Shares subject to redemption are recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.”

If the Company seeks shareholder approval of the Business Combination, the Company will proceed with a Business Combination only if the Company receives an ordinary resolution under Cayman Islands law and its Amended and Restated Articles approving a Business Combination, which requires the affirmative vote of at least a majority of the votes cast by such shareholders as, being entitled to do so, vote in person or by proxy at the applicable general meeting of the Company, or such other vote as required by law or stock exchange rule. If the Company’s Business Combination is structured as a statutory merger or consolidation with another company under Cayman Islands law, the approval of its Business Combination will also require a special resolution, which requires the affirmative vote of at least two-thirds of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the Company. If a shareholder vote is not required under applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Articles, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange

6

Table of Contents

Commission (the “SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Prior Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination and waive its redemption rights with respect to any such shares in connection with a shareholder vote to approve a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares without voting and, if they do vote, irrespective of whether they vote for or against the proposed Business Combination.

Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Articles provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without the Company’s prior written consent.

The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Articles (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment.

If the Company has not completed a Business Combination within 18 months from the closing of the Initial Public Offering or during any extended time to consummate a Business Combination beyond 18 months (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter (and subject to lawfully available funds therefor), redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.

The Sponsor has agreed to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares it will receive if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or any of its respective affiliates acquire Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period, and in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Public Share ($10.05).

In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.05 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.05 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of this offering against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has it independently verified whether the Sponsor has sufficient funds to satisfy its indemnity

7

Table of Contents

obligations, and the Company believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. As a result, if any such claims were successfully made against the Trust Account, the funds available for the Company’s initial Business Combination and redemptions could be reduced to less than $10.05 per Public Share. In such event, the Company may not be able to complete its initial Business Combination, and the Public Shareholders would receive such lesser amount per share in connection with any redemption of their Public Shares. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.

Going Concern Considerations

At September 30, 2025, the Company had cash of $876,477 and working capital of $984,113.

Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the Initial Public Offering and the Private Placement held outside of the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 5). Management expects the Company to incur significant expenses as a result of identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. As a result, management has determined that the current liquidity condition of the Company, coupled with the fact that the Company is within one year of mandatory liquidation, these factors raise substantial doubt about the Company’s ability to continue as a going concern.

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in unaudited condensed financial statements prepared in accordance with US GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on April 24, 2025, as well as the Company’s Current Report on Form 8-K, as filed with the SEC on May 1, 2025. The interim results for the three and nine months ended September 30, 2025 are not necessarily indicative of the results to be expected for the year ending December 31, 2025 or for any future periods.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different

8

Table of Contents

application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2025 and December 31, 2024.

Offering Costs Associated with the Initial Public Offering

The offering costs consisted of legal, accounting, underwriting and other costs incurred that were directly related to the Initial Public Offering and that were charged to shareholders’ deficit upon the completion of the Initial Public Offering.

The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering.” Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. Financial Accounting Standards Board (“FASB”) ASC 470-20, “Debt with Conversion and Other Options,” addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate the Initial Public Offering proceeds from the Units between ordinary shares and warrants, using the residual method by allocating the Initial Public Offering proceeds first to assigned value of the warrants and then to the ordinary shares. Offering costs allocated to the Public Shares are charged to temporary equity and offering costs allocated to the Public and Private Placement Warrants are charged to shareholders’ deficit as Public and Private Placement Warrants after management’s evaluation are accounted for under equity treatment. Offering costs allocated the NMSI Private Placement Warrants were charged to the statements of operations as the NMSI Warrants after management’s evaluation are accounted for as liabilities.

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2025 and December 31, 2024. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

There is currently no taxation imposed on income by the government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements.

9

Table of Contents

Investments Held in Trust Account

As of September 30, 2025, the Company had $230,239,464 invested in mutual funds held in the Trust Account. The Company’s portfolio of investments held in the Trust Account are invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act.

Net Income (Loss) per Ordinary Share

Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. Basic weighted average shares were reduced for the 1,000,000 shares subject to forfeiture and were subsequently adjusted following the partial exercise by the underwriters (see Note 5). The calculation of diluted income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering and (ii) the Private Placement. Diluted earnings per share differs from basic earnings per share. For diluted earnings per share, the Class B non-redeemable ordinary shares subject to forfeiture are included in the calculation of total diluted shares at the beginning of the interim period in which the contingency was resolved. For basic earnings per share, the forfeited Class B non-redeemable ordinary shares are considered forfeited on the date of forfeiture.

The following tables reflect the calculation of basic net income (loss) per ordinary share.

​ | ​ | ​ | ​
​ |  | For the
​ |  | Nine Months Ended
​ |  | September 30,
​ | ​ | 2025
Class A ordinary shares subject to possible redemption |  | ​ | ​
Numerator: Allocation of net income, basic | ​ | $ | 1,052,603
Denominator: Basic weighted average shares outstanding | ​ |  | 11,648,352
Basic net income per Class A Ordinary share subject to possible redemption | ​ | $ | 0.09
Class B Non-redeemable ordinary shares | ​ |  |
Numerator: Allocation of net income, basic | ​ | $ | 646,292
Denominator: Basic weighted average shares outstanding | ​ |  | 7,152,015
Basic net income per Class B Ordinary Share | ​ | $ | 0.09

​

​ | ​ | ​ | ​
​ |  | For the
​ |  | Three Months Ended
​ |  | September 30,
​ | ​ | 2025
Class A ordinary shares subject to possible redemption |  | ​ | ​
Numerator: Allocation of net loss, basic | ​ | $ | (873,204)
Denominator: Basic weighted average shares outstanding | ​ |  | 20,000,000
Basic net loss per Class A Ordinary share subject to possible redemption | ​ | $ | (0.04)
Class B Non-redeemable ordinary shares | ​ |  |
Numerator: Allocation of net loss, basic | ​ | $ | (327,452)
Denominator: Basic weighted average shares outstanding | ​ |  | 7,500,000
Basic net loss per Class B Ordinary Share | ​ | $ | (0.04)

​

10

Table of Contents

​ | ​ | ​ | ​
​ |  | For the Period from
​ | ​ | July 26, 2024 (Inception) through
​ | ​ | September 30,
​ | ​ | 2024
Class A ordinary shares subject to possible redemption |  | ​ |
Numerator: Allocation of net loss, basic | ​ | $ | —
Denominator: Basic weighted average shares outstanding | ​ |  | —
Basic net loss per Class A Ordinary share subject to possible redemption | ​ | $ | —
Class B Non-redeemable ordinary shares | ​ |  |
Numerator: Allocation of net loss, basic | ​ | $ | (26,450)
Denominator: Basic weighted average shares outstanding | ​ |  | 6,666,667
Basic net loss per Class B Ordinary Share | ​ | $ | (0.00)

​

The following tables reflect the calculation of diluted net income (loss) per ordinary share.

​ | ​ | ​ | ​
​ |  | For the
​ |  | Nine Months Ended
​ |  | September 30,
​ | ​ | 2025
Class A ordinary shares subject to possible redemption |  | ​ | ​
Numerator: Allocation of net income, diluted | ​ | $ | 1,048,687
Denominator: Diluted weighted average shares outstanding | ​ |  | 11,648,352
Diluted net income per Class A Ordinary share subject to possible redemption | ​ | $ | 0.09
Class B Non-redeemable ordinary shares | ​ |  |
Numerator: Allocation of net income, diluted | ​ | $ | 650,208
Denominator: Diluted weighted average shares outstanding | ​ |  | 7,222,222
Diluted net income per Class B Ordinary Share | ​ | $ | 0.09

​

​ | ​ | ​ | ​
​ |  | For the
​ |  | Three Months Ended
​ |  | September 30,
​ | ​ | 2025
Class A ordinary shares subject to possible redemption |  | ​ |
Numerator: Allocation of net loss, diluted | ​ | $ | (873,204)
Denominator: Diluted weighted average shares outstanding | ​ |  | 20,000,000
Diluted net loss per Class A Ordinary share subject to possible redemption | ​ | $ | (0.04)
Class B Non-redeemable ordinary shares | ​ |  |
Numerator: Allocation of net loss, diluted | ​ | $ | (327,452)
Denominator: Diluted weighted average shares outstanding | ​ |  | 7,500,000
Diluted net loss per Class B Ordinary Share | ​ | $ | (0.04)

​

​ | ​ | ​ | ​
​ |  | For the Period from
​ | ​ | July 26, 2024 (Inception) through
​ | ​ | September 30,
​ | ​ | 2024
Class A ordinary shares subject to possible redemption |  | ​ |
Numerator: Allocation of net loss, diluted | ​ | $ | —
Denominator: Diluted weighted average shares outstanding | ​ |  | —
Diluted net loss per Class A Ordinary share subject to possible redemption | ​ | $ | —
Class B Non-redeemable ordinary shares | ​ |  |
Numerator: Allocation of net loss, diluted | ​ | $ | (26,450)
Denominator: Diluted weighted average shares outstanding | ​ |  | 6,666,667
Diluted net loss per Class B Ordinary Share | ​ | $ | (0.00)

​

11

Table of Contents

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation limit. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the condensed balance sheets, primarily due to their short-term nature.

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

| ● | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

| ● | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

| ● | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the condensed statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the condensed balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

Warrant Instruments

The Company accounts for the Public Warrants issued in connection with the Initial Public Offering, the Private Placement Warrants and the NMSI Private Placement Warrants in accordance with the guidance contained in FASB ASC 815, “Derivatives and Hedging”. Under ASC 815-40, the Public Warrants and the Private Placement Warrants meet the criteria for equity treatment and as such are recorded in shareholders’ deficit. The NMSI Private Placement Warrants do not meet the criteria for equity treatment and as such are recorded as a liability and remeasured each period with changes recorded in the condensed statements of operations. If the Public and Private Placement Warrants no longer meet the criteria for equity treatment, they will record as a liability and be remeasured each period with changes recorded in the condensed statements of operations.

12

Table of Contents

Class A Ordinary Shares Subject to Redemption

The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of September 30, 2025, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s condensed balance sheets.

Accordingly, as of September 30, 2025, the Class A ordinary shares subject to redemption reflected in the balance sheets are reconciled in the following table:

​

​ | ​ | ​ | ​
Gross proceeds |  | $ | 225,000,000
Less: Proceeds allocated to public warrants | ​ |  | (3,037,500)
Less: Class A ordinary share issuance costs | ​ |  | (13,802,579)
Add: Remeasurement of carrying value to redemption value | ​ |  | 19,698,991
Class A ordinary shares subject to redemption, June 30, 2025 | ​ | $ | 227,858,912
Add: Remeasurement of carrying value to redemption value | ​ | ​ | 2,380,552
Class A ordinary shares subject to possible redemption, September 30, 2025 | ​ | $ | 230,239,464

​

Recent Accounting Standards

In November 2023, the FASB issued Accounting Standards Update 2023-07, “Segment Reporting — Improvements to Reportable Segment Disclosures.” This update requires public entities to disclose its significant segment expense categories and amounts for each reportable segment. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. As of September 30, 2025, the Company reported its operations as a single reportable segment, noting no disaggregation of Company activities, management or allocation of resources by geographic region, business activity or organizational method, thus this new guidance does not affect the disclosures. See Note 10 for further information.

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

NOTE 3 — INITIAL PUBLIC OFFERING

Pursuant to the Initial Public Offering on April 24, 2025, the Company sold 22,500,000 Public Units at a purchase price of $10.00 per Public Unit. Each Public Unit consists of one Class A ordinary share and one-half of one redeemable Public Warrant. Each whole Public Warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment.

13

Table of Contents

NOTE 4 — PRIVATE PLACEMENT

Simultaneously with the consummation of the Initial Public Offering on April 24, 2025 and the sale of the Units, the Company consummated the Private Placement of Private Placement Warrants. The Prior Sponsor, Cohen & Company and Clear Street purchased an aggregate of 7,568,750 warrants, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.00 per warrant, or $7,568,750. Cohen & Company and Clear Street purchased an aggregate of 2,868,750 Private Placement Warrants and the Prior Sponsor purchased 4,700,000 Private Placement Warrants (including the 4,100,000 NMSI Private Placement Warrants). Each Private Placement Warrant is exercisable to purchase one Class A ordinary share at $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants was placed in the Trust Account with the net proceeds from the Initial Public Offering. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants will expire worthless. The Private Placement Warrants (including the Class A ordinary shares issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable or salable until 30 days after the completion of an initial Business Combination, subject to certain exceptions (see Note 8).

NOTE 5 — RELATED PARTIES

Founder Shares

On August 1, 2024, the Prior Sponsor received 7,666,667 of the Company’s Class B ordinary shares (the “Founder Shares”) in exchange for a payment of $25,000.

On April 24, 2025, 166,667 Founder Shares were forfeited as the underwriters did not fully exercise the over-allotment option.

On September 18, 2025, pursuant to the Purchase Agreement, the Prior Sponsor sold 7,500,000 Founder Shares and 4,700,000 Private Placement Warrants to the New Sponsor for an aggregate purchase price of $7,400,000, and, upon closing, the New Sponsor became the Company’s sponsor.

The New Sponsor has agreed not to transfer or sell any of their Founder Shares and any Class A ordinary shares issuable upon conversion thereof until the closing of the Company’s initial Business Combination; except to affiliates, members or partners of the Sponsor or their affiliates, or any employees of such affiliates, provided that in each case the transferee agrees in writing to be bound by the terms of the Insider Letter. In connection with the Purchase, the parties also entered into a joinder to and amendment of the Registration Rights Agreement that removed lock‑up obligations under that agreement for the New Sponsor.

General and Administrative Services

Commencing on the effective date of the Initial Public Offering on April 24, 2025 and through the earlier of the Company’s consummation of a Business Combination or its liquidation, the Company has agreed to pay the Sponsor or an affiliate thereof a monthly fee of $10,000 for office space, utilities and secretarial and administrative support. For the nine months ended September 30, 2025, the Company had incurred and paid the Prior Sponsor $50,000 of administrative costs. Pursuant to the Purchase Agreement executed on September 18, 2025, the Administrative Services Agreement with the Prior Sponsor was terminated and no further fees accrue thereafter.

Due from Prior Sponsor

As of April 24, 2025, the consummation date of the Initial Public Offering, the Prior Sponsor had not transferred funds totaling $600,000 from the Prior Sponsor’s account to the Company’s operating account for the purchase of Private Warrants. As such, there was an amount due from the Prior Sponsor of $600,000 as of April 24, 2025. On May 1, 2025, the Prior Sponsor transferred these funds to the operating account and settled the $600,000 balance.

14

Table of Contents

Promissory Notes — Related Party

On August 1, 2024, the Prior Sponsor issued an unsecured promissory note (the “Promissory Note”) to the Company, pursuant to which the Company may borrow up to an aggregate principal amount of up to $300,000. The Promissory Note is non-interest bearing and payable on the earlier of (i) December 31, 2024, or (ii) the consummation of the Initial Public Offering. On March 14, 2025, the Company amended and restated the Promissory Note to extend the maturity date of the Promissory Note from December 31, 2024 to December 31, 2025. As of September 30, 2025 and December 31, 2024, there was $0 and $152,200 outstanding under the Promissory Note, respectively. As of September 30, 2025 the Promissory Note is not available for further draw down.

Working Capital Loans

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of the notes may be converted upon completion of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of September 30, 2025 and December 31, 2024, there was no amount outstanding under the Working Capital Loans.

NOTE 6 — COMMITMENTS AND CONTINGENCIES

Registration Rights

The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of Initial Public Offering requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class A ordinary shares). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain piggyback registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their lockup restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Risks and Uncertainties

The Company’s results of operations and its ability to complete an initial Business Combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond the Company’s control. The Company’s results of operations and its ability to consummate an initial Business Combination could be impacted by, among other things, various social and political circumstances in the U.S. and around the world (including wars and other forms of conflict, including rising trade tensions between the United States and China, and other uncertainties regarding actual and potential shifts in the U.S. and foreign, trade, economic and other policies with other countries, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics) that may contribute to increased market volatility and economic uncertainties or deterioration in the U.S. and worldwide. Specifically, the rising conflict between Russia and Ukraine, and the rising conflicts in the Middle East, and resulting market volatility could adversely affect the Company’s ability to complete a business combination. In response to the conflict between Russia and Ukraine, the U.S. and other countries have imposed sanctions or other restrictive actions against Russia. Any of the above factors, including sanctions, export controls, tariffs, trade wars and other governmental actions, could have a material adverse effect on the Company’s ability to complete a Business Combination and the value of the Company’s securities. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

15

Table of Contents

Underwriting Agreement

The Company granted the underwriters a 45-day option from the date of the Initial Public Offering to purchase up to 3,000,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts. In connection with the Initial Public Offering on April 24, 2025, the underwriters exercised the option and purchased 2,500,000 additional Units. On April 24, 2025, the underwriters advised the Company that it would not further exercise the option for the remaining 500,000 Units.

The underwriters were paid a cash underwriting discount of $0.20 per share, or $4,500,000 in the aggregate, upon the closing of the Initial Public Offering. In addition, the underwriters are entitled to a deferred fee of $0.40 per share, or up to $9,000,000 in the aggregate. The deferred fee will become payable to the underwriter based on the percentage of funds remaining in the Trust Account after redemptions of Public Shares, for deferred underwriting commissions to be placed in the Trust Account located in the United States solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

NOTE 7 — SHAREHOLDERS’ DEFICIT

Preference Shares — The Company is authorized to issue 5,000,000 preference shares with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2025 and December 31, 2024, there were no preference shares issued or outstanding.

Class A Ordinary Shares — The Company is authorized to issue 500,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. As of September 30, 2025 and December 31, 2024, there were no Class A Ordinary Shares issued or outstanding, excluding 22,500,000 Class A ordinary shares subject to possible redemption.

Class B Ordinary Shares — The Company is authorized to issue 50,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders of Class B ordinary shares are entitled to one vote for each share. As of September 30, 2025 and December 31, 2024, there were 7,500,000 and 7,666,667 Class B ordinary shares issued and outstanding, respectively. On April 24, 2025, 166,667 of the 1,000,000 Founder Shares subject to forfeiture were forfeited as the underwriters did not fully exercise the over-allotment option. Only holders of the Class B ordinary shares have the right to vote on the appointment of directors prior to the Business Combination. Only holders of the Class B ordinary shares will have the right to vote on the appointment of directors of the Company prior to the Business Combination.

Holders of ordinary shares will vote together as a single class on all matters submitted to a vote of shareholders except as otherwise required by law. In connection with the initial Business Combination, the Company may enter into a shareholders agreement or other arrangements with the shareholders of the target or other investors to provide for voting or other corporate governance arrangements that differ from those in effect upon completion of the Initial Public Offering.

The Founder Shares are designated as Class B ordinary shares and will automatically convert at a ratio of one-for-one into Class A ordinary shares (which such Class A ordinary shares delivered upon conversion will not have redemption rights or be entitled to liquidating distributions from the Trust Account if the Company does not consummate an initial Business Combination) at the time of the initial Business Combination.

NOTE 8 — WARRANTS

In connection with the Initial Public Offering as of April 24, 2025, and as of September 30, 2025, there were 18,818,500 warrants outstanding, including 11,250,000 Public Warrants, 7,568,750 Private Placement Warrants (inclusive of the 4,100,000 NMSI Private Placement Warrants owned by the Prior Sponsor that were allocated to the non-managing sponsor investors as a result of the non-managing sponsor investor’s membership interests in the Prior Sponsor).

On September 18, 2025, the Company, the Prior Sponsor and the New Sponsor entered into the Purchase Agreement. Pursuant to the Purchase Agreement, the New Sponsor (i) purchased from the Prior Sponsor (a) 7,500,000 shares of Class B Ordinary Shares and (b) 4,700,000 Private Placement Warrants (including the 4,100,000 NMSI Private Placement Warrants) for an aggregate purchase price of $7,400,000 and (ii) upon closing, became the sponsor of the Company. After the closing of the Purchase Agreement, the non-managing sponsor investors ceased to have any rights, claims, or interests in or to any Sponsor held securities.

16

Table of Contents

Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

The Company will not be obligated to deliver any Class A ordinary share pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of residence of the exercising holder, or an exemption from registration is available.

The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, the Company will use its commercially reasonable efforts to file, and within 60 business days following a Business Combination to have declared effective, a registration statement covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed. Notwithstanding the above, if the Class A ordinary share is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

Redemption of Warrants. When the price per Class A ordinary share equals or exceeds $18.00, the warrants become exercisable and the Company may redeem the outstanding Public Warrants:

| ● | in whole and not in part;

| ● | at a price of $0.01 per Public Warrant;

| ● | upon a minimum of 30 days’ prior written notice of redemption, or the 30-day redemption period to each warrant holder; and

| ● | if, and only if, the last reported sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share splits, share dividends, reorganization, recapitalizations and the like).

| ● | for any 10 trading days within a 20-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to warrant holders.

If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial business combination at less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by its board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or its affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of its initial Business Combination on the date of the completion of its initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A ordinary shares during the 20 day trading period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price.

17

Table of Contents

The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or saleable until 30 days after the completion of a Business Combination, subject to certain limited exceptions.

NOTE 9 — FAIR VALUE MEASUREMENTS

The following table presents information about the Company’s assets and liabilities that are measured at fair value at September 30, 2025 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. The Company did not have any fair value measurements as of December 31, 2024.

​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | September 30,
Description |  | Level |  | 2025
Assets: |  |  |  | ​ |
Investments held in Trust Account |  | 1 | ​ | $ | 230,239,464
Liabilities: |  |  | ​ |  | ​
Warrant Liability – NMSI Warrants |  | 3 | ​ | $ | 6,133,664

​

The NMSI Warrants were accounted for as a liability in accordance with ASC 815-40 and are presented within liabilities in the balance sheet. The Warrant liabilities are measured at fair value.

The table below provides a summary of the changes in fair value of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the nine months ended September 30, 2025:

​ | ​ | ​ | ​
​ |  | Fair Value
​ |  | Measurement
​ |  | Using Level 3
​ |  | Inputs Total
Balance, December 31, 2024 | ​ | $ | —
Initial fair value | ​ |  | 4,100,000
Change in fair value of derivative warrant liabilities | ​ |  | 2,033,664
Balance, September 30, 2025 | ​ | $ | 6,133,664

​

The Company used a Monte Carlo simulation model to value the NMSI Warrants at April 24, 2025.

​ | ​ | ​ | ​
​ |  | April 24,
​ |  | 2025
NMSI Warrants | ​ | $ | 2,480,500

​

The Company used the following assumptions to value the Public Warrants, Private Placement Warrants and NMSI Warrants at April 24, 2025.

​ | ​ | ​ | ​ | ​
Volatility |  | ​ | 6.6 | %
Risk Free Rate |  | ​ | 3.8 | %
Dividends | ​ | $ | 0.00 | ​
Market Adjustment | ​ |  | 16.7 | %
Stock Price | ​ | $ | 9.87 | ​
Weighted Term (years) | ​ |  | 2.83 | ​

​

18

Table of Contents

The Company used the following assumptions to value the NMSI Warrants at September 30, 2025.

​ | ​ | ​ | ​ | ​
Volatility |  | ​ | 24.8 | %
Risk Free Rate |  | ​ | 3.65 | %
Dividends | ​ | $ | 0.00 | ​
Market Adjustment | ​ |  | 18.9 | %
Stock Price | ​ | $ | 10.71 | ​
Weighted Term (years) | ​ |  | 1.41 | ​

​

​

NOTE 10 — SEGMENT INFORMATION

ASC Topic 280, “Segment Reporting,” establishes standards for companies to report, in their financial statements, information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker (“CODM”), or group, in deciding how to allocate resources and assess performance.

The Company’s CODM has been identified as the Chief Financial Officer, who reviews the assets, operating results, and financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one reporting segment.

The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the condensed statements of operations as net income or loss. The measure of segment assets is reported on the condensed balance sheets as total assets. When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net income or loss and total assets, which include the following:

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | September 30, | ​ | December 31,
​ |  | 2025 |  | 2024
Cash | ​ | $ | 876,477 | ​ | $ | 2,232
Investments held in Trust Account | ​ | $ | 230,239,464 | ​ | $ | —

​

​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | For the |  | For the
​ | ​ | Nine Months Ended | ​ | Three Months Ended
​ | ​ | September 30, | ​ | September 30,
​ | ​ | 2025 | ​ | 2025
General and administrative expenses | ​ | $ | 427,662 | ​ | $ | 151,150
​ | ​ | ​ | ​ | ​ | ​ | ​
Interest income earned on investments held in Trust Account | ​ | $ | 4,114,464 | ​ | $ | 2,380,552

​

​ | ​ | ​ | ​
​ |  | For the
​ | ​ | Period from July
​ | ​ | 26, 2024 (Inception) through
​ | ​ | September 30, 2024
General and administrative expenses | ​ | $ | 26,450
​ | ​ | ​ | ​
Interest income earned on investments held in Trust Account | ​ | $ | —

​

19

Table of Contents

General and administrative expenses are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination or similar transaction within the business combination period. The CODM also evaluates general and administrative expenses to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. General and administrative, as reported on the condensed statements of operations, are the significant segment expenses provided to the CODM on a regular basis.

All other segment items included in net loss are reported on the condensed statements of operations and described within their respective disclosures.

NOTE 11 — SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the accompanying unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the accompanying unaudited condensed financial statements.

​

20

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Cautionary Note Regarding Forward-Looking Statements

All statements other than statements of historical fact included in this Report including, without limitation, statements under this Item regarding our financial position, business strategy and the plans and objectives of Management for future operations, are forward-looking statements. When used in this Report, words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to us or our Management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of our Management, as well as assumptions made by, and information currently available to, our Management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in our filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto included in this Report under “Item 1. Financial Statements”.

Overview

We are a blank check company incorporated in the Cayman Islands on July 26, 2024, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or other similar Business Combination with one or more businesses. We intend to effectuate our Business Combination using cash derived from the proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, our shares, debt or a combination of cash, shares and debt.

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

We may seek to extend the Combination Period consistent with applicable laws, regulations and stock exchange rules by amending our Amended and Restated Articles. Any such amendment would require the approval of our Public Shareholders, who will be provided the opportunity to redeem all or a portion of their Public Shares in connection with the vote on such approval. Such redemptions will decrease the amount held in our Trust Account and our capitalization, and may affect our ability to maintain our listing on Nasdaq. In addition, the Nasdaq Rules currently require SPACs (such as us) to complete our initial Business Combination in accordance with the Nasdaq 36-Month Requirement. If we do not meet the Nasdaq 36-Month Requirement, our securities will likely be subject to a suspension of trading and delisting from Nasdaq. Our Sponsor may also, in its discretion, consider selling its interest in our Company to another sponsor entity, which may result in a change to our Management Team.

Results of Operations

We have neither engaged in any operations nor generated any revenues to date. Our only activities since July 26, 2024 (inception) through September 30, 2025 have been (i) organizational activities and (ii) activities relating to (x) the Initial Public Offering, and (y) identifying and evaluating prospective acquisition candidates and activities in connection with the initial Business Combination. We will not generate any operating revenues until after the completion of our Business Combination. Following our Initial Public Offering, we have generated non-operating income in the form of interest income on investments held in the Trust Account. We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance, among other things), as well as for due diligence expenses.

For the three months ended September 30, 2025, we had a net loss of $1,200,656 which was primarily due to interest earned on investments held in the Trust Account of $2,380,552, interest earned on cash held in operating accounts of $10,674, and forgiveness of debt of $28,614, partially offset by change in fair value of warrant liability of $3,469,346 and general and administrative expenses of $151,150.

For the nine months ended September 30, 2025, we had net income of $1,698,895 which was primarily due to interest earned on investments held in the Trust Account of $4,114,464, interest earned on cash held in operating accounts of $17,143, and forgiveness of debt of $28,614, partially offset the change in fair value of warrant liability of $2,033,664 and general and administrative expenses of $427,662.

21

Table of Contents

For the period from July 26, 2024 (Inception) through September 30,2024, we had a net loss of $26,450 which was primarily due to general and administrative expenses of $26,450.

Liquidity and Capital Resources

Until the consummation of the Initial Public Offering, our only source of liquidity was an initial purchase of shares of Class B ordinary shares by the Prior Sponsor and loans from the Prior Sponsor.

On April 24, 2025, we consummated our Initial Public Offering of 22,500,000 Public Units, including 2,500,000 Units issued pursuant to the partial exercise of the underwriters’ over-allotment option. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to us of $225,000,000.

Following the Initial Public Offering and the Private Placement, a total of $226,125,000 ($10.05 per Unit) was placed in the Trust Account.

We incurred offering costs of $14,006,902, including underwriting fees of $4,500,000, deferred underwriting fees of $9,000,000 and other costs of $506,902.

We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less deferred underwriting commissions and taxes payable), to complete our initial Business Combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies. To mitigate the risk that we might be deemed to be an investment company for purposes of the Investment Company Act, which risk increases the longer that we hold investments in the Trust Account, we may, at any time, (based on our Management Team’s ongoing assessment of all factors related to our potential status under the Investment Company Act) instruct the trustee to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest-bearing demand deposit account at a bank.

We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, structure, negotiate and complete a Business Combination.

In order to finance working capital deficit or to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor may, but are not obligated to, loan us funds as may be required. If we complete the initial Business Combination, we would repay the Working Capital Loans. In the event that the initial Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of the Working Capital Loans may be convertible into Private Placement Warrants of the post Business Combination entity at a price of $1.00 per Private Placement Warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants.

Our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination may be less than the actual amount necessary to do so, in which case we may have insufficient funds available to operate our business prior to our initial Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our Public Shares upon completion of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.

We may need to raise additional capital through loans or additional investments from our Sponsor, shareholders, officers, directors, or third parties. Our officers, directors and our Sponsor may, but are not obligated to, loan us funds as may be required. Accordingly, we may not be able to obtain additional financing. If we are unable to raise additional capital, we may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. We cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions, coupled with being one year from mandatory liquidation, raise substantial doubt about our ability to continue as a going concern for a reasonable period of time which is considered to be one year from the date of the issuance of the unaudited condensed financial statements, the date that we will be required to cease all operations, except for the purpose of winding up, if a Business Combination is not consummated. The unaudited condensed financial statements do not include

22

Table of Contents

any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should we be unable to continue as a going concern.

Off-Balance Sheet Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2025. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities. We previously had a monthly administrative services of $10,000 for office space, utilities and secretarial and administrative support. We began incurring these fees on April 24, 2025. Pursuant to the Purchase Agreement executed on September 18, 2025, the Administrative Services Agreement with the Prior Sponsor was terminated.

The underwriters are entitled to a deferred underwriting fee of $0.40 per share, or up to $9,000,000 in the aggregate. The deferred fee will become payable to the underwriters based on the percentage of funds remaining in the Trust Account after redemptions of Public Shares, for deferred underwriting commissions to be placed in a Trust Account located in the United States solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement.

Critical Accounting Policies and Estimates

The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:

A critical accounting estimate to our financial statements is the estimated fair value of our warrant liability. Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

| ● | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

| ● | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

| ● | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

Warrant Liabilities

We account for the Public Warrants issued in connection with the Initial Public Offering, the Private Placement Warrants and the NMSI Private Placement Warrants in accordance with the guidance contained in FASB ASC 815, “Derivatives and Hedging”. Under ASC 815-40, the Public Warrants and the Private Placement Warrants meet the criteria for equity treatment and as such are recorded in shareholders’ deficit. On September 18, 2025, in connection with the Purchase Agreement, the Prior Sponsor sold 4,700,000 Private Placement Warrants (including the 4,100,000 NMSI Private Placement Warrants) to the New Sponsor. After the closing of the Purchase Agreement, the non-managing sponsor investors ceased to have any rights, claims or interests in or to any Sponsor held securities. The

23

Table of Contents

NMSI Private Placement Warrants do not meet the criteria for equity treatment and as such are recorded as a liability and remeasured each period with changes recorded in the condensed statements of operations. If the Public and Private Placement Warrants no longer meet the criteria for equity treatment, they will record as a liability and remeasured each period with changes recorded in the condensed statements of operations.

Class A Ordinary Shares Subject to Possible Redemption

We account for our ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. Our Class A ordinary shares feature certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption is presented as temporary equity, outside of the shareholders’ equity section of our balance sheet.

Net Income Per Share

Net income per ordinary share is computed by dividing net income by the weighted average number of ordinary shares outstanding during the period. We apply the two-class method in calculating earnings per share. The net income is allocated to each class of shares using an allocation of total shares, which is then divided by the total shares for the respective class.

We did not consider the effect of the Warrants issued in connection with the Initial Public Offering and the Private Placement in the calculation of diluted income per share because their exercise is contingent upon future events. As a result, diluted net income per Ordinary Share is the same as basic net income per Ordinary Share. Accretion associated with the redeemable Class A Ordinary Shares is excluded from income per Ordinary Share as the redemption value approximates fair value.

Recent Accounting Standards

In November 2023, the FASB issued Accounting Standards Update 2023-07 — Segment Reporting — Improvements to Reportable Segment Disclosures (“ASU 2023-07”). This update requires public entities to disclose its significant segment expense categories and amounts for each reportable segment. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. As of September 30, 2025, we reported our operations as a single reportable segment, noting no disaggregation of Company activities, management or allocation of resources by geographic region, business activity or organizational method, thus this new guidance does not affect the disclosures.

We do not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our financial statements.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this Item.

24

Table of Contents

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Report, is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures are also designed with the objective of ensuring that such information is accumulated and communicated to our Management, including our Chief Executive Officer and Chief Financial Officer (together, the “Certifying Officers”), or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our Management, including our Certifying Officers, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on the foregoing, our Certifying Officers concluded that our disclosure controls and procedures were effective as of September 30, 2025.

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Changes in Internal Control over Financial Reporting

Not applicable.

​

25

Table of Contents

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

To the knowledge of our Management Team, there is no material litigation currently pending or contemplated against us, any of our officers or directors in their capacity as such or against any of our property.

Item 1A. Risk Factors

As a smaller reporting company under Rule 12b-2 of the Exchange Act, we are not required to include risk factors in this Report. For additional risks relating to our operations, see the section titled “Risk Factors” contained in our (i) IPO Registration Statement and (ii) Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025 as filed with the SEC on June 6, 2025. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risks could arise that may also affect our ability to consummate an initial Business Combination. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Unregistered Sales of Equity Securities

There were no sales of unregistered securities during the quarterly period covered by the Report. However, simultaneously with the closing of the Initial Public Offering and pursuant to the Private Placement Warrants Purchase Agreements, we completed the sale of an aggregate of 7,568,750 Private Placement Warrants to the Prior Sponsor, Cohen & Company and Clear Street in the Private Placement at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to us of $7,568,750. Of those 7,568,750 Private Placement Warrants, the Prior Sponsor purchased 4,700,000 Private Placement Warrants (including the 4,100,000 NMSI Private Placement Warrants) and Cohen & Company and Clear Street purchased an aggregate of 2,868,750 Private Placement Warrants. The Private Placement Warrants (and underlying securities) are identical to the Public Warrants, except that, so long as they are held by our Sponsor or its permitted transferees, the Private Placement Warrants (i) may not (including the Class A ordinary shares issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of our initial business combination, (ii) will be entitled to registration rights and (iii) with respect to Private Placement Warrants held by Cohen & Company and/or its designees, will not be exercisable more than five years from the commencement of sales in the IPO in accordance with FINRA Rule 5110(g)(8)(A). If we do not complete our initial Business Combination within the completion window, the Private Placement Warrants will expire worthless. No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

Use of Proceeds

There have been no offerings of registered securities and therefore no planned use of proceeds from such offerings during the quarterly period covered by the Report. For a description of the use of proceeds generated in our Initial Public Offering and Private Placement, see Part II, Item 2 of our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025, as filed with the SEC on June 6, 2025. There has been no material change in the planned use of proceeds from our Initial Public Offering and Private Placement as described in the IPO Registration Statement. The specific investments in our Trust Account may change from time to time.

Item 3. Defaults upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

N o n e.

​

26

Table of Contents

Item 6. Exhibits

The following exhibits are filed as part of, or incorporated by reference into, this Report on Form 10-Q.

Exhibit No. |  | Description
1.1 | ​ | Underwriting Agreement, dated April 22, 2025, with Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC, as representative of the several underwriters (incorporated by reference to Exhibit 1.1 to Current Report on Form 8-K filed with the SEC on April 28, 2025).
3.1 | ​ | Amended and Restated Memorandum and Articles of Association (incorporated by reference to Exhibit 3.1 to Current Report on Form 8-K filed with the SEC on April 28, 2025).
4.1 | ​ | Specimen Unit Certificate (incorporated by reference to Exhibit 4.1 to Amendment No. 1 to the Registration Statement on Form S‑1 (File No. 333‑284793), filed with the SEC on March 18, 2025)
4.2 | ​ | Specimen Warrant Certificate (incorporated by reference to Exhibit 4.3 to the Registration Statement on Form S‑1 (File No. 333‑284793)).
4.3 | ​ | Specimen Ordinary Share Certificate (incorporated by reference to Exhibit 4.2 to Amendment No. 1 to the Registration Statement on Form S‑1 (File No. 333‑284793), filed with the SEC on March 18, 2025).
4.4 | ​ | Warrant Agreement, dated April 22, 2025, by and between Continental Stock Transfer & Trust Company and the Company (incorporated by reference to Exhibit 4.1 to Current Report on Form 8-K filed with the SEC on April 28, 2025).
10.1 | ​ | Securities Subscription Agreement, dated August 1, 2024, between the Company and TV Partners III, LLC (incorporated by reference to Exhibit 10.9 to Amendment No. 2 to the Registration Statement on Form S‑1 (File No. 333‑284793), filed with the SEC on April 4, 2025).
10.2 | ​ | Investment Management Trust Agreement, dated April 22, 2025, by and between Continental Stock Transfer & Trust Company and the Company (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed with the SEC on April 28, 2025).
10.3 | ​ | Administrative Services Agreement, dated April 22, 2025, by and between the Company and TV Partners III, LLC (incorporated by reference to Exhibit 10.6 to Current Report on Form 8-K filed with the SEC on April 28, 2025).
10.4 | ​ | Registration Rights Agreement, dated April 22, 2025, by and among the Company and certain security holders (incorporated by reference to Exhibit 10.2 to Current Report on Form 8-K filed with the SEC on April 28, 2025).
10.5 | ​ | Private Placement Warrants Purchase Agreement, dated April 22, 2025, between the Company and TV Partners III, LLC (incorporated by reference to Exhibit 10.3 to Current Report on Form 8-K filed with the SEC on April 28, 2025).
10.6 | ​ | Private Placement Warrants Purchase Agreement, dated April 22, 2025, by and among the Company, Cohen & Company Capital Markets and Clear Street LLC (incorporated by reference to Exhibit 10.4 to Current Report on Form 8-K filed with the SEC on April 28, 2025).
10.7 | ​ | Amended and Restated Promissory Note issued to TV Partners III, LLC (incorporated by reference to Exhibit 10.8 of the Company’s Form S-1, as amended, filed with the SEC on April 4, 2025).
10.8 | ​ | Form of Indemnity Agreement, (incorporated by reference to Exhibit 10.6 of the Company’s Form S-1, as amended, filed with the SEC on April 4, 2025).
10.9 | ​ | Letter Agreement, dated April 22, 2025, by and among the Company, its officers and directors, and TV Partners III, LLC (incorporated by reference to Exhibit 10.5 to Current Report on Form 8-K filed with the SEC on April 28, 2025).
10.10 | ​ | Purchase Agreement, dated September 18, 2025, by and among Texas Ventures Acquisition III Corp, TV Partners III, LLC, and Yorkville Acquisition Sponsor II, LLC (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed with the SEC on September 24, 2025).
10.11 | ​ | Insider Letter, dated September 18, 2025, by and among Yorkville Acquisition Sponsor II, LLC, the Insiders and Texas Ventures Acquisition III Corp (incorporated by reference to Exhibit 10.2 to Current Report on Form 8-K filed with the SEC on September 24, 2025).
10.12 | ​ | Joinder to and Amendment of the Registration Rights Agreement, dated September 18, 2025, by Yorkville Acquisition Sponsor II, LLC, and acknowledged and accepted by Texas Ventures Acquisition III Corp and TV Partners III, LLC (incorporated by reference to Exhibit 10.3 to Current Report on Form 8-K filed with the SEC on September 24, 2025).
31.1 |  | Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2 |  | Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32 |  | Certification of the Principal Executive Officer and the Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS |  | Inline XBRL Instance Document.
101.SCH |  | Inline XBRL Taxonomy Extension Schema Document.
101.CAL |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF |  | Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB |  | Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104 |  | Cover Page Interactive Data File (Embedded as Inline XBRL document and contained in Exhibit 101).

​

​

27

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| TEXAS VENTURES ACQUISITION III CORP
Date: November 19, 2025 | By: | /s/ Kevin McGurn
| Name: | Kevin McGurn
| Title: | Chief Executive Officer
|  | (Principal Executive Officer)
Date: November 19, 2025 | By: | /s/ Troy Rillo
| Name: | Troy Rillo
| Title: | Chief Financial Officer
|  | (Principal Financial and Accounting Officer)

​

​

​

28